Occurrence of a new melanocyte stimulating hormone in the salmon pituitary gland

A new melanocyte stimulating hormone has been identified in the pituitary of the teleost, $\text{Oncorhynchus keta}$ (chum salmon). The newly isolated MSH like peptide is a heptadeca peptide, which differs in size from salmon α-MSH (13 residues) and β-MSH I and II (17 residues each). The structural determination, however, revealed that it is similar to but distinct form α-MSH, with following amino acid sequence, Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Ile-Gly-His-OH. This peptide, named α-MSH II is the third line of evidence in the salmon that the teleost pituitary gland secretes two different forms of processed hormones, for which the precursor molecules are coded on two separate genes.     

A comparison of extraction methods for the isolation of phospholipids from biological sources

Four classical methods, as well as a method presented in this paper, were compared as to their efficiency in extracting phospholipids from animal tissue. After the extractions, total lipids were separated quantitatively by DEAE-Sephadex chromatography into their acidic and nonacidic fractions. The two fractions were then further analyzed by gradient saturation high-performance thin-layer chromatography (HPTLC) combined with scanning photodensitometry after coloration with copper acetate. Of the five methods compared, the present and Christiansen's methods based upon single-phase solvent systems proved to be more efficient than biphasic extraction procedures. The undesirable discriminatory effect exhibited by biphasic solvent systems toward acidic phospholipids which were partly retained in the aqueous phase was confirmed by statistical evaluation of the HPTLC results. Total chromogenic response of acidic phospholipids extracted using biphasic solvent systems was shown to be lower by 10-35% in comparison to the single-phase method of Christiansen. The suitability of the present method for studies involving phospholipid synthesis was confirmed by monitoring the elimination of water-soluble compounds from the single-phase extracts using a classical phospholipid precursor, 2-[3H]glycerol-3-phosphate. The labeled compound was eliminated (99.3-100%) from the single-phase postcentrifugation supernatant, followed by DEAE-Sephadex chromatography.     

Circadian variation in plasma melanocyte stimulating hormone activity in the rat.

Non--stress levels of plasma melanocyte stimulating hormone (MSH) and corticosterone were determined at 3-h intervals during controlled light--dark cycles in adult, male rats. Significant 24-h periodicity was demonstrated for both plasma MSH and corticosterone. Whereas plasma MSH values were not as high during the early evening hours as during the early morning hours, plasma corticosterone levels showed a marked rise during the early afternoon and crest values occurred just before the lights off phase of the 24-h light--dark cycle. These results indicate that in the rat, the level of MSH in plasma fluctuates with a low amplitude circadian frequency which is not in phase with that observed for plasma corticosterone.     

Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA.

Melanocytes and melanoma cells are known to possess receptors for melanocyte stimulating hormone (MSH). A cDNA clone, designated 11D, has been isolated from human melanoma cells and encodes a MSH receptor. The cloned cDNA encodes a 317 amino acid protein with transmembrane topography characteristics of a G-protein-coupled receptor, but it does not show striking similarity to already published sequences of other G-protein-coupled receptors. When 11D cDNA is expressed in COS-7 cells, it binds an 125I-labelled MSH analogue (NDP-MSH) in a specific manner. The bound ligand could be displaced by melanotropic peptides, alpha-MSH, beta-MSH, gamma-MSH and ACTH (adrenocorticotropic hormone), but not by the non-melanotropic peptide, beta-endorphin. This is the first report of the cloning of the receptor gene of the melanotropin receptor family.     

Alpha melanocyte stimulating hormone inhibits immunostimulatory and inflammatory actions of interleukin 1

The ability of interleukin 1 (IL 1) to augment the proliferation of murine thymocytes in vitro was inhibited in a dose-dependent manner by the neuropeptide alpha-melanocyte-stimulating hormone (alpha MSH). The minimal effective concentration of alpha MSH was 10(-11) M. Maximal effect occurred between 10(-8) and 10(-7) M, with diminishing effectiveness at higher concentrations. IL 1-induced production of prostaglandin E (PGE) by fibroblasts was also inhibited by alpha MSH with a biphasic dose response. The minimal effective concentration was 10(-11) M, and maximum effect was achieved at 10(-10) M. alpha MSH appeared to affect the interaction of IL 1 with its target cells in a specific manner, because it did not inhibit basal mitogen-induced thymocyte proliferation or IL 2-induced proliferation of a cytotoxic T lymphocyte line. Furthermore, production of IL 1 by endotoxin-stimulated monocytes was not affected by alpha MSH. An analog of alpha MSH (Nle4, D-Phe7 alpha MSH), which is highly potent in other melanotropin-sensitive systems, did not affect the action of IL 1 on thymocytes, suggesting that the immunomodulatory effects of alpha MSH may not be mediated by the classic melanocyte alpha MSH receptor. The influence of alpha MSH on thymocytes and fibroblasts suggests that alpha MSH is an endogenous antagonist of IL 1, perhaps important for limiting inflammatory damage to host tissues.     

Abba Kastin: The melanocyte stimulating hormone story and the future of the proteophathies

From a personal viewpoint, Abba was always a congenial colleague and a good friend. I recall the hours of unraveling complex, confusing, and many times contradictory data sets with him and the excitement we both felt as what had been puzzling began to make sense. Most of all, I feel privileged to have Abba as a long and valued friend.     

Alpha melanocyte stimulating hormone inhibits prolactin secretion in fetal and infant lambs

The intravenous administration of αMSH (25 μg/kg) to 11 lambs (3 to 29 days of age) suppressed plasma PRL by 15 minutes. The mean basal concentration was 15.3 ± 2.9 ng/ml and the mean nadir was 4.9 ± 0.8 ng/ml (p<0.01). In chronically catheterized fetuses (128–140 days), intravenous administration of αMSH (25 μg/kg) decreased basal PRL levels (89.6 ± 12.4 ng/ml) significantly at 15–30 minutes to levels of 74.3 ± 11.4 ng/ml (p<.01). The degree of suppression of basal PRL levels was less in fetusus (76.9 ± 4.1%) than that induced in the neonates (40.5 ± 7.1%). In younger fetuses <120 days in whom basal PRL levels are low (3.0 ± 2.1 ng/ml), administration of αMSH was without effect. Plasma GH concentrations were not altered by administration of αMSH. The suppression of PRL secretion by αMSH administration could result from increased release of hypothalamic dopamine or be a direct effect on secretion of prolactin by the pituitary.     

Direct in vitro stimulation of pituitary LH release by alpha melanocyte stimulating hormone

The present $\text{in vitro}$ superfusion study demonstrates that synthetic α-MSH acts at the pituitary level, independent of the hypothalamus, to increase the release of LH in male but not in female rats.     

A comparison of methods for the isolation and fractionation of reticulocyte ribosomes

1. Polysomes, ribosomes and pH5 enzymes were isolated from rabbit reticulocytes by acidifying the post-mitochondrial supernatant to pH6.0 to precipitate all ribonucleoprotein particles and about half the pH5 enzymes; the precipitate was redissolved in buffer, pH7.6, and fractionated by zone centrifuging. 2. The isolation of polysome-rich and ribosome-rich fractions from the post-mitochondrial supernatant was also examined. 3. Studies of the stability of polysomes revealed that dissociation into sub-units occurred when both bound and free Mg(2+) was chelated by EDTA or when the pH was increased above pH8.8.     

Immunohistochemical localization of adrenocorticotropin and melanocyte stimulating hormone in pars intermedia of rat hypophysis

Summary The sites of production of adrenocorticotropin (ACTH) and melanocyte stimulating hormone (MSH) are studied by the immunoglobulin-peroxidase bridge technique, using antisera prepared against synthetic porcine 1–24 and 17–39 ACTH, and bovine MSH on the rat adenohypophysis. Presence of ACTH all over the pars intermedia (PI) is indicated by staining with antisera _p 1–24 and _p 17-3-9 ACTH. There are darkly stained ACTH cells in the PI and pars tuberalis (PT), similar to those in the pars distalis (PD). With higher dilutions of the ACTH antiserum, staining intensity disappears or reduces markedly in majority of the PI cells, whereas, the ACTH cells in the PI, PD and PT do not vary much in their staining intensity. Therefore, it is concluded that majority of the PI glandular cells (light glandular and dark cells) contain less corticotropin than the ACTH cells. From these observations, it seems to me that the major amount of corticotropin is supplied by the ACTH cells of the PD, PI and PT, and less by the light glandular and dark cells of the PI. The antiserum is ineffective after absorption, so the staining reaction appears to be specific for _p 1–24 and _b 17–39 ACTH.Presence of MSH all over the PI is indicated by staining with antisera to bovine MSH. Majority of the PI cells are highly stained even with higher dilution of the antiserum. The unstained cells in the PI seem to be ACTH cells and/or marginal cuboidal cells. The antiserum was ineffective after absorption, so the staining reaction appears to be specific for _b MSH.Control over the PD corticotropin through the median eminence portal circulation and the PI and PT control through nervous system is also discussed.This study was supported by MRC of Canada Grant nos. MA-3759, and MA-5160.The author gratefully wishes to thank Drs. P. Desaulles and W. Rittel (CIBA, Basle, Switzerland) for the synthetic _p 1–24 ACTH and _b MSH, Dr. R. F. Phifer for _p 17–39 ACTH, and Dr. S. S. Spicer for providing samples of rabbit anti-porcine 17–39 ACTH and anti-human ACTH sera, Drs. George Sétáló and Paul Nakane for their valuable advice. He also acknowledges the help of Mr. Shankar Nayak to prepare the antisera and the skilful technical assistance of Miss. Elise Poiré.     

A radioimmunoassay for gamma-melanocyte stimulating hormone

A specific radioimmunoassay for γ-melanocyte stimulating hormone-like peptides has been developed. An antiserum raised in rabbit to synthetic bovine γ₃-MSH, one of the possible γ-MSH peptides, specifically recognizes the portion between His⁵ and Arg¹⁴ of γ₃-MSH without significant cross-reaction with other synthetic γ-MSH-like peptides, α-, β-MSH, adrenocorticotropin, and β-endorphin. The usable range of this RIA is 10 pg to 600 pg of synthetic γ₃-MSH. Three immunoreactive γ-MSH peaks were thus found in gel permeation chromatography of the whole bovine pituitary extract.     

Characterization and isolation of melanocyte progenitors from mouse embryos

Whole mount immunohistochemistry and flow cytometry have been used to determine the morphological and molecular features that distinguish melanoblasts from surrounding cells. Whole mount immunohistochemistry of mouse embryos using anti-c-Kit monoclonal antibody revealed two distinct types of c-Kit⁺ cells; one dendritic and the other round in shape. The distribution of c-Kit⁺ dendritic cells in 12.5 days postcoitem embryos correlated well with that of tyrosinase-related protein-2 expression, while the distribution of c-Kit⁺ round cells overlaps that of CD45⁺ cells. This observation suggests that melanoblasts are distinguishable from other c-Kit⁺ cells by their dendritic shape. Mice homozygous for the steel-Dickie mutation (Sl^d/Sl^d) were analyzed to further distinguish melanoblasts from hematopoietic progenitor cells. Sl^d/Sl^d mice are unpigmented but contain hematopoietic cells, although reduced in number. Although no c-Kit⁺ dendritic cells were detectable in the Sl^d/Sl^d embryos, a significant number of c-Kit⁺ round cells were present in the same embryos. To further analyze characteristic features of melanoblasts, c-Kit⁺CD45^? and c-Kit⁺CD45⁺ cells were isolated from dissociated embryonic skin by fluorescent activated cell sorter and the expression of TRP2 melanogenic enzyme was analyzed. Consistent with histological analysis, most c-Kit⁺CD45^? cells were TRP2⁺.c-Kit⁺CD45⁺ cells failed to express TRP2. These results show that most of the melanoblasts are c-Kit⁺TRP2⁺CD45^? dendritic cells and can be discriminated from other cells by flow cytometry or by their morphology.     

The postnatal developmental localization of pro-opiomelanocortin and alpha melanocyte stimulating hormone in the medio-basal hypothalamus of the rat

This immunocytochemical study of the late postnatal development of the medio-basal hypothalamus revealed the presence of ACTH 1-39 like positivity in neurons of the arcuate nucleus form the begin of this study (day E 18-20) onwards. Alpha MSH positivity, on the contrary, is not present in cells of the same area before day P 16. No other areas in the developing medio-basal hypothalamus contain perikaryal positivity for alpha M-SH or ACTH 1-39. The pituitary contains ACTH 1-39 like positivity from the begin of this study (day E 18-20) onwards. Fibers are positive for alpha MSH during the fetal development of the medio-basal hypothalamus, demonstrating an overal reactivity without varicosities and restricted to bundles or neuropil areas. Towards P 16 the alpha MSH positivity diminishes in the whole medio-basal hypothalamus, remaining present only in large fibre systems like the fornix. ACTH 1-39 like fiber positivity is already distributed in arcuate and periventricular regions at days E 20-PO, reaching its mature extension at day P2. After P16 alpha MSH positive threads, possessing varicosities are restricted to the same areas as ACTH 1-39 like fiber positivity is.     

Immunoreactive α melanocyte stimulating hormone,its distribution in the gastrointestinal tract of intact and hypophysectomized rats

The presence of immunoreactive α melanocyte stimulating hormone (IαMSH) was investigated in both mucosal and muscular layers of the various areas of the gastrointestinal tract. IαMSH was present in both layers in all areas of the gastrointestinal tract but the esophageal mucosa and muscularis in saline extracts. The highest concentrations were found in the duodenum. Hypophysectomized males tended to have higher content than intact males. There was no difference between intact estrogen-primed females and hypophysectomized females up to 1 month post hypophysectomy in any area. The tract of 3 month hypophysectomized females showed lower levels than the intact estrogen-primed females in 5 areas; however, in similar groups of 3 month hypophysectomized females which were estrogen primed, 8 of the 10 areas contained more IαMSH than the intact estrogen-primed females. Acid extracts from female rats during the estrous cycle showed no cycle-dependent differences. Comparison of acid and saline extracts showed an absence of IαMSH in gastric tissues and a decrease in the duodenal muscularis in acid extracts but no consistent differences were found in other areas. These results suggest that the IαMSH found in the gastrointestinal tract is not of pituitary origin but may be produced in the gastrointestinal tract. The induction of increased content by estrogen priming in hypophysectomized rats suggests that estrogen priming may induce production. The absence of IαMSH in acid extracts of the stomach suggests that a difference in distribution of pro-opio-cortin products may exist in the gastrointestinal tract.     

alpha-MSH (melanocyte stimulating hormone) and MCH (melanin concentrating hormone) actions in Bufo ictericus ictericus melanophores

1. The darkening actions of MCH (melanin concentrating hormone), alpha-MSH and the synthetic analog [Nle4, D-Phe7]-alpha-MSH on the toad, Bufo ictericus ictericus, melanophores were studied regarding the role of calcium in the hormone receptor coupling, signal transduction and intracellular pigment translocation. 2. In the absence of external calcium, MCH and both melanotropins still elicit maximal skin darkening. 3. Verapamil, a calcium-channel blocker, completely abolishes the alpha-MSH-induced response and partially inhibits MCH-induced darkening, although the calcium carrier, ionophore A23187, was unable to promote any pigment translocation. 4. Since darkening responses promoted by cyclic nucleotides proceeded normally in the presence of verapamil and extracellular calcium was not necessary for melanotropin dispersing action, it is suggested that the blocking activity obtained with verapamil is probably due to an impairment of the Ca2+-dependent adenylate cyclase activity. 5. Reversal of melanotropin-induced darkening could be obtained with melatonin, in both normal and Ca2+-free Ringer, whereas MCH darkening is reversed by melatonin only in the absence of calcium. 6. The results seem to indicate that calcium is not required for hormone receptor binding and pigment migration, whereas it is specifically needed for signal transduction.